114 related articles for article (PubMed ID: 19382301)
21. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
Cacoub P; Lidove O; Maisonobe T; Duhaut P; Thibault V; Ghillani P; Myers RP; Leger JM; Servan J; Piette JC
Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of ribavirin plus interferon-alpha in patients aged >or=60 years with chronic hepatitis C.
Honda T; Katano Y; Urano F; Murayama M; Hayashi K; Ishigami M; Nakano I; Yoshioka K; Toyoda H; Kumada T; Goto H
J Gastroenterol Hepatol; 2007 Jul; 22(7):989-95. PubMed ID: 17608843
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and clinical relevance of serum autoantibodies in patients with chronic hepatitis C.
Chen CH; Lee CM; Chen CH; Hu TH; Wang JH; Hung CH; Chung CH; Lu SN
Chang Gung Med J; 2010; 33(3):258-65. PubMed ID: 20584503
[TBL] [Abstract][Full Text] [Related]
24. Screening for autoantibodies in chronic hepatitis C patients has no effect on treatment initiation or outcome.
Mauss S; Berger F; Schober A; Moog G; Heyne R; John C; Pape S; Hueppe D; Pfeiffer-Vornkahl H; Alshuth U
J Viral Hepat; 2013 Apr; 20(4):e72-7. PubMed ID: 23490392
[TBL] [Abstract][Full Text] [Related]
25. Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis C.
Ferri S; Muratori L; Quarneti C; Muratori P; Menichella R; Pappas G; Granito A; Ballardini G; Bianchi FB; Lenzi M
J Hepatol; 2009 Jun; 50(6):1093-101. PubMed ID: 19398235
[TBL] [Abstract][Full Text] [Related]
26. Autoantibodies in chronic hepatitis C virus infection and their association with disease profile.
Williams MJ; Lawson A; Neal KR; Ryder SD; Irving WL;
J Viral Hepat; 2009 May; 16(5):325-31. PubMed ID: 19302340
[TBL] [Abstract][Full Text] [Related]
27. The presence of non-organ-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis C.
Wasmuth HE; Stolte C; Geier A; Dietrich CG; Gartung C; Lorenzen J; Matern S; Lammert F
BMC Infect Dis; 2004 Feb; 4():4. PubMed ID: 15040810
[TBL] [Abstract][Full Text] [Related]
28. Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection.
Betterle C; Fabris P; Zanchetta R; Pedini B; Tositti G; Bosi E; de Lalla F
Diabetes Care; 2000 Aug; 23(8):1177-81. PubMed ID: 10937518
[TBL] [Abstract][Full Text] [Related]
29. Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: a pilot study.
Gatselis NK; Georgiadou SP; Tassopoulos N; Zachou K; Liaskos C; Hatzakis A; Dalekos GN
World J Gastroenterol; 2005 Jan; 11(4):482-7. PubMed ID: 15641130
[TBL] [Abstract][Full Text] [Related]
30. Expression and clinical significance of antinuclear antibody in hepatitis C virus infection.
Peng YC; Hsieh SC; Yang DY; Tung CF; Hu WH; Huang WN; Chen GH
J Clin Gastroenterol; 2001; 33(5):402-6. PubMed ID: 11606858
[TBL] [Abstract][Full Text] [Related]
31. [Investigation of antinuclear antibodies in chronic hepatitis B patients].
Şener AG; Aydın N; Ceylan C; Kırdar S
Mikrobiyol Bul; 2018 Oct; 52(4):425-430. PubMed ID: 30522427
[TBL] [Abstract][Full Text] [Related]
32. [Clinical significance of dense fine speckled pattern in anti-nuclear antibody test using indirect immunofluorescence method].
Kang SY; Lee WI
Korean J Lab Med; 2009 Apr; 29(2):145-51. PubMed ID: 19411782
[TBL] [Abstract][Full Text] [Related]
33. Does an 'autoimmune' profile affect the clinical profile of chronic hepatitis C? An Italian multicentre survey.
Stroffolini T; Colloredo G; Gaeta GB; Sonzogni A; Angeletti S; Marignani M; Pasquale G; Venezia G; Craxì A; Almasio P
J Viral Hepat; 2004 May; 11(3):257-62. PubMed ID: 15117328
[TBL] [Abstract][Full Text] [Related]
34. Induction of antinuclear antibody after interferon therapy in patients with type-C chronic hepatitis: its relation to the efficacy of therapy.
Noda K; Enomoto N; Arai K; Masuda E; Yamada Y; Suzuki K; Tanaka M; Yoshihara H
Scand J Gastroenterol; 1996 Jul; 31(7):716-22. PubMed ID: 8819224
[TBL] [Abstract][Full Text] [Related]
35. Autoimmune hepatitis with acute presentation in Japan.
Miyake Y; Iwasaki Y; Kobashi H; Yasunaka T; Ikeda F; Takaki A; Yamamoto K
Dig Liver Dis; 2010 Jan; 42(1):51-4. PubMed ID: 19473895
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of the antinuclear antibodies in chronic viral hepatitis B in children.
Pop TL; Stefănescu A; Samaşca G; Miu N
Clin Lab; 2014; 60(6):931-9. PubMed ID: 25016697
[TBL] [Abstract][Full Text] [Related]
37. Clinical correlates of the "rods and rings" antinuclear antibody pattern.
Climent J; Morandeira F; Castellote J; Xiol J; Niubó J; Calatayud L; Mestre M; Bas J
Autoimmunity; 2016; 49(2):102-8. PubMed ID: 26699543
[TBL] [Abstract][Full Text] [Related]
38. Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis.
Czaja AJ; Cassani F; Cataleta M; Valentini P; Bianchi FB
Dig Dis Sci; 1997 Aug; 42(8):1688-96. PubMed ID: 9286235
[TBL] [Abstract][Full Text] [Related]
39. High prevalence of antinuclear antibodies in patients with chronic hepatitis C virus infection.
de Castro GLC; da Silva Graça Amoras E; Araújo MS; da Silva Conde SRS; Bichara CDA; Queiroz MAF; Vallinoto ACR
Eur J Med Res; 2022 Sep; 27(1):180. PubMed ID: 36114565
[TBL] [Abstract][Full Text] [Related]
40. Autoantibody in a patient with chronic hepatitis C virus infection showing complete remission after interferon therapy.
Akashi Y; Inoh M; Seto K; Gamo N; Kuboki M; Kurata N
J Gastroenterol Hepatol; 2002 Aug; 17(8):925-8. PubMed ID: 12164971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
